The city of Cary, North Carolina, currently has 1 active clinical trials seeking participants for Type 2 Diabetes research studies.
A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
Recruiting
This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of CT-388 at low, middle, and high doses in participants who are overweight or obese with Type 2 diabetes mellitus (T2DM).
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
06/10/2025
Locations: Accellacare of Cary, Cary, North Carolina
Conditions: Overweight or Obese, Type 2 Diabetes Mellitus (T2DM)